Open Access Highly Accessed Research article

Doxorubicin-enriched, ALDHbr mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1

Xiufen Zhuang1, Wen Zhang1, Yatong Chen2, Xiangping Han34, Jie Li1, Yu Zhang1, Youhui Zhang1, Shuren Zhang1* and Binlei Liu134*

Author Affiliations

1 Department of Immunology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 17 Panjiayuan Nanli Chaoyang District, Beijing, 100021, China

2 Department of Urologic Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China

3 Department of Biochemistry and Molecular Biology, College of Life Sciences, Nankai University, Tianjin, 300192, China

4 Tianjin International Joint Academy of Biotechnology & Medicine, Tianjin, 300457, China

For all author emails, please log on.

BMC Cancer 2012, 12:549  doi:10.1186/1471-2407-12-549

Published: 23 November 2012

Additional files

Additional file 1:

Figure S1. Toxicity comparison of four different treatment groups in vivo.

Format: DOC Size: 925KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data